We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Minister of State for Women's Health, Baroness Merron, spoke at the Responsible AI: Women and Healthcare Conference 2025, in London.
The government's pandemic planning has been stepped up in response to recommendations from the Covid-19 Inquiry Module 1 report.
£5.5 million to go towards vital research projects to tackle ongoing mpox outbreaks in DRC and neighbouring countries.
Scientists at VDEC use ‘organ-on-a-chip’ models to study infections and immune responses, aiming to improve vaccine testing and reduce reliance on animal research.
Professor Anthony Harnden has officially started his role as Chair of the Medicines and Healthcare products Regulatory Agency (MHRA).
How DASA helped an SME break down challenges in prosthetic care
The amended regulatory framework will speed up trial approvals and encourage innovation in trial design without compromising patient safety
20 new clinical research hubs to be set up across UK to accelerate research into the next generation of treatments.
UK and Switzerland update science and research partnership to focus on some of today’s most pressing challenges, from healthcare to green energy.
The pilot scheme, AI Airlock, is designed to help test and improve the rules for AI-powered medical devices to ensure they reach patients quickly, safely and effectively.
£22.6 million invested in innovative projects across the country to support unpaid carers as well as people with care needs.
Oxford Nanopore’s breakthrough genetic sequencing tech to analyse 50,000 samples from UK Biobank, to create a world-first ‘epigenetic map’.
Responses will help shape reforms that will boost UK patients’ access to safe and innovative medical products
The government is set to partner with Oxford Nanopore, which uses technology to rapidly diagnose a range of cancers, along with rare and infectious diseases.
A new strategy is being published to radically cut the number of single-use medical devices in the health service.
Collaboration announced at International Investment Summit, meeting the PM's ambitions to catalyse investment in the UK and proving the UK is open for business.
The Health and Social Care Secretary spoke at the Royal College of General Practitioners (RCGP) annual conference 2024, in Liverpool.
World-first public-private collaboration launched to kickstart economic growth and build an NHS fit for the future.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 22 August 2024, approved a product licence for the medicine lecanemab (Leqembi) for use in the early stages of Alzheimer’s disease, following a thorou…
ACE has been a strategic partner in developing the patient-centred app and rolling out new features for secondary care across England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).